Search alternatives:
remove. » removed. (Expand Search), remote. (Expand Search)
resolved. » resulted. (Expand Search)
remove. » removed. (Expand Search), remote. (Expand Search)
resolved. » resulted. (Expand Search)
-
1641
REDEFINE (UK): Participatory observation on the ACM construction site
Published 2025“…<p dir="ltr">This document forms part of the REDEFINE research project (ERC Grant No. 885475), funded by the European Research Council. …”
-
1642
-
1643
Table 2_The dysbiosis of gut microbiota and dysregulation of metabolites in IgA nephropathy and membranous nephropathy.xlsx
Published 2025“…Introduction<p>Immunoglobulin A nephropathy (IgAN) and membranous nephropathy (MN) are among the most common forms of primary glomerular diseases, with a rising global incidence. …”
-
1644
Table 6_The dysbiosis of gut microbiota and dysregulation of metabolites in IgA nephropathy and membranous nephropathy.xlsx
Published 2025“…Introduction<p>Immunoglobulin A nephropathy (IgAN) and membranous nephropathy (MN) are among the most common forms of primary glomerular diseases, with a rising global incidence. …”
-
1645
Table 3_The dysbiosis of gut microbiota and dysregulation of metabolites in IgA nephropathy and membranous nephropathy.xlsx
Published 2025“…Introduction<p>Immunoglobulin A nephropathy (IgAN) and membranous nephropathy (MN) are among the most common forms of primary glomerular diseases, with a rising global incidence. …”
-
1646
Table 1_The dysbiosis of gut microbiota and dysregulation of metabolites in IgA nephropathy and membranous nephropathy.xlsx
Published 2025“…Introduction<p>Immunoglobulin A nephropathy (IgAN) and membranous nephropathy (MN) are among the most common forms of primary glomerular diseases, with a rising global incidence. …”
-
1647
Table 5_The dysbiosis of gut microbiota and dysregulation of metabolites in IgA nephropathy and membranous nephropathy.xlsx
Published 2025“…Introduction<p>Immunoglobulin A nephropathy (IgAN) and membranous nephropathy (MN) are among the most common forms of primary glomerular diseases, with a rising global incidence. …”
-
1648
Table 4_The dysbiosis of gut microbiota and dysregulation of metabolites in IgA nephropathy and membranous nephropathy.xlsx
Published 2025“…Introduction<p>Immunoglobulin A nephropathy (IgAN) and membranous nephropathy (MN) are among the most common forms of primary glomerular diseases, with a rising global incidence. …”
-
1649
Characteristics of FGD and IDI participants.
Published 2025“…Strengthening the health system’s capacity to ensure availability and affordability of treatment and diagnosis services, creation of community hypertension awareness, adequate patient counselling at screening and diagnosis, and involvement of family caregivers for older patients are examples of urgent interventions to improve access to hypertension care.…”
-
1650
REDEFINE (Greece): Interview with a local government official A
Published 2025“…<p dir="ltr">This document forms part of the REDEFINE research project (ERC Grant No. 885475), funded by the European Research Council. …”
-
1651
REDEFINE (Hungary): Interview with an Investigative Journalist A
Published 2025“…<p dir="ltr">This document forms part of the REDEFINE research project (ERC Grant No. 885475), funded by the European Research Council. …”
-
1652
REDEFINE (Greece): Interview with a former finance minister
Published 2025“…<p dir="ltr">This document forms part of the REDEFINE research project (ERC Grant No. 885475), funded by the European Research Council. …”
-
1653
REDEFINE (Germany): Interview with a community activist
Published 2025“…<p dir="ltr">This document forms part of the REDEFINE research project (ERC Grant No. 885475), funded by the European Research Council. …”
-
1654
REDEFINE (Germany): Interview with an MP A
Published 2025“…<p dir="ltr">This document forms part of the REDEFINE research project (ERC Grant No. 885475), funded by the European Research Council. …”
-
1655
REDEFINE (Germany): Interview with an MEP B
Published 2025“…<p dir="ltr">This document forms part of the REDEFINE research project (ERC Grant No. 885475), funded by the European Research Council. …”
-
1656
REDEFINE (Germany): Interview with an industry representative A
Published 2025“…<p dir="ltr">This document forms part of the REDEFINE research project (ERC Grant No. 885475), funded by the European Research Council. …”
-
1657
REDEFINE (UK): Group Discussion with Chinese student representatives of a UK university
Published 2025“…<p dir="ltr">This document forms part of the REDEFINE research project (ERC Grant No. 885475), funded by the European Research Council. …”
-
1658
REDEFINE (Germany): Interview with a board member D of company
Published 2025“…<p dir="ltr">This document forms part of the REDEFINE research project (ERC Grant No. 885475), funded by the European Research Council. …”
-
1659
REDEFINE (Germany): Interview with a lawyer A
Published 2025“…<p dir="ltr">This document forms part of the REDEFINE research project (ERC Grant No. 885475), funded by the European Research Council. …”
-
1660
REDEFINE (Germany): Interview with an MP E of Hamburg Parliament
Published 2025“…<p dir="ltr">This document forms part of the REDEFINE research project (ERC Grant No. 885475), funded by the European Research Council. …”